International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation

被引：0

作者：

A Palumbo

O Sezer

R Kyle

J S Miguel

R Z Orlowski

P Moreau

R Niesvizky

G Morgan

R Comenzo

P Sonneveld

S Kumar

R Hajek

S Giralt

S Bringhen

K C Anderson

P G Richardson

M Cavo

F Davies

J Bladé

H Einsele

M A Dimopoulos

A Spencer

A Dispenzieri

T Reiman

K Shimizu

J H Lee

M Attal

M Boccadoro

M Mateos

W Chen

H Ludwig

D Joshua

J Chim

V Hungria

I Turesson

B G M Durie

S Lonial

机构：

[1] Azienda Ospedaliera S. Giovanni Battista,Divisione di Ematologia dell'Università di Torino

[2] Ospedale Molinette,Department of Hematology/Oncology

[3] Charité–Universitaetsmedizin Berlin,Division of Hematology

[4] Mayo Clinic,Department of Lymphoma/Myeloma

[5] Servicio de Hematología,Department of Clinical Hematology

[6] Hospital Universitario de Salamanca. CIC,Department of Hematology

[7] IBMCC (USAL-CSIC),Department of Internal Medicine

[8] The University of Texas MD Anderson Cancer Center,Department of Medical Oncology

[9] University Hospital,Department of Hematology

[10] Center for Lymphoma and Myeloma,Department of Clinical Therapeutics

[11] Weill Medical College of Cornell University,Department of Haematology

[12] Institute of Cancer Research,Department of Medicine

[13] Royal Marsden Hospital,Department of Internal Medicine

[14] Blood Bank and Stem Cell Processing Laboratory,Division of Hematology

[15] Tufts Medical Center,Oncology

[16] Erasmus MC,Department of Hematology

[17] University Hospital Brno,Department of Biostatistics

[18] Dana-Farber Cancer Institute,Department of Hematology

[19] Institute of Hematology and Medical Oncology,Department of Oncology

[20] Hospital Clinic,First Medical Department and Medical Oncology

[21] Universitätsklinik Würzburg,Department of Medicine

[22] Medizinische Klinik und Poliklinik II,Department of Hematology

[23] University of Athens School of Medicine,Department of Hematology/Medicine

[24] The Alfred Hospital,Department of Hematology

[25] Cross Cancer Institute,undefined

[26] Nagoya City Midori General Hospital,undefined

[27] Gachon University Gil Hospital,undefined

[28] Service d'Hématologie,undefined

[29] Hôpital Purpan,undefined

[30] Service d'Hématologie,undefined

[31] Hôpital Purpan,undefined

[32] Beijing Chaoyang Hospital,undefined

[33] Capital Medical University,undefined

[34] Beijing Chaoyang Hospital,undefined

[35] Capital Medical University,undefined

[36] Wilhelminenspital,undefined

[37] Institute of Hematology,undefined

[38] Royal Prince Alfred Hospital,undefined

[39] Bosch University of Sydney,undefined

[40] Queen Mary Hospital,undefined

[41] Clinica São Germano,undefined

[42] Malmö University Hospital,undefined

[43] Aptium Oncology Inc.,undefined

[44] Cedars-Sinai Outpatient Cancer Center at the Samuel Oschin Comprehensive Cancer Institute,undefined

[45] Emory University,undefined

来源：

Leukemia | 2009年 / 23卷

关键词：

myeloma; guidelines; treatment; chemotherapy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

In 2005, the first guidelines were published on the management of patients with multiple myeloma (MM). An expert panel reviewed the currently available literature as the basis for a set of revised and updated consensus guidelines for the diagnosis and management of patients with MM who are not eligible for autologous stem cell transplantation. Here we present recommendations on the diagnosis, treatment of newly diagnosed non-transplant-eligible patients and the management of complications occurring during induction therapy among these patients. These guidelines will aid the physician in daily clinical practice and will ensure optimal care for patients with MM.

引用

页码：1716 / 1730

页数：14

共 356 条

[1]

Smith A(2005)Guidelines on the diagnosis and management of multiple myeloma 2005 Br J Haematol 132 410-451

[2]

Wisloff F(2008)Cancer statistics, 2008 CA Cancer J Clin 58 71-96

[3]

Samson D(2003)Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation Hematol J 4 379-398

[4]

Jemal A(2009)International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma Leukemia 23 1545-1556

[5]

Siegel R(2009)International Myeloma Working Group guidelines for serum free light chain analysis in multiple myeloma and related disorders Leukemia 23 215-224

[6]

Ward E(1993)Initial versus deferred melphalan-prednisone therapy for asymptomatic myltiple myeloma stage I—a randomized study Eur J Haematol 50 95-102

[7]

Hao Y(2000)Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of disease: a multicentre randomized study Br J Cancer 82 1254-1260

[8]

Xu J(2005)International staging system for multiple myeloma J Clin Oncol 23 3412-3420

[9]

Murray T(2008)Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system Leukemia 22 1933-1937

[10]

Durie BGM(2008)Incorporation of the bone marker carboxy-terminal telopeptide of type-1 collagen improves prognostic information of the International Staging System in newly diagnosed symptomatic multiple myeloma Leukemia 22 1767-1772

← 1 2 3 4 5 6 7 8 9 10 →